Oncology & Cancer

Prostate cancer screening declined following 2012 USPSTF guidance

(HealthDay)—There were large temporal changes in screening, biopsy, overall cancer detection, and metastatic cancer rates following the 2012 U.S. Preventive Services Task Force (USPSTF) Prostate Cancer Screening Statement, ...

Oncology & Cancer

PSA testing rates up in the U.S. after change in guidance

(HealthDay)—Rates of prostate-specific antigen (PSA) testing increased significantly after the 2017 U.S. Preventive Services Task Force (USPSTF) draft statement on prostate cancer screening, reversing trends that resulted ...

Medications

Statin use affects prostate cancer screening results

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did not increase the incidence ...

Oncology & Cancer

New blood test improves prostate cancer screening

Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a ...

Oncology & Cancer

MRI can cut overdiagnoses in prostate-cancer screening by half

Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which ...

Alzheimer's disease & dementia

Changes in the eye may offer early warning for Alzheimer's disease

Some say the eyes are the windows to the soul, but new findings from researchers at the Johns Hopkins Wilmer Eye Institute suggest they may offer insight into the mind as well. Their new proof-of-principle study shows how ...

page 5 from 25